ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,411Medicare Part D Prescriptions Filled, Including Refills

Rank: 133 out of 761

$466K Total Retail Price of All Prescriptions

Rank: 147 out of 761

480 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
15% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oregon
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 480 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

16% of this provider’s 480 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

1% of this provider’s 8,734 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oregon
SIMVASTATIN 621 605 1 2
LISINOPRIL 444 398 2 1
AMLODIPINE BESYLATE 418 413 3 6
LEVOTHYROXINE SODIUM 411 375 4 3
ATORVASTATIN CALCIUM 310 298 5 12
ATENOLOL 261 248 6 8
HYDROCODONE-ACETAMINOPHEN 257 222 S3 7 5
OMEPRAZOLE 249 241 8 4
METFORMIN HCL 244 224 9 10
GABAPENTIN 208 179 10 15
HYDROCHLOROTHIAZIDE 205 205 11 11
FUROSEMIDE 196 187 12 7
CITALOPRAM HBR 193 179 13 19
WARFARIN SODIUM 184 184 14 9
CARVEDILOL 149 149 15 26
METOPROLOL SUCCINATE 145 145 16 16
ZOLPIDEM TARTRATE 133 120 17 22
METOPROLOL TARTRATE 120 120 18 14
ALENDRONATE SODIUM 118 109 19 21
TAMSULOSIN HCL 105 93 20 27
CYMBALTA 100 69 21 53
TRAZODONE HCL 92 92 22 23
LOSARTAN POTASSIUM 84 83 23 13
POTASSIUM CHLORIDE 82 82 24 18
CRESTOR 76 75 25 36
LISINOPRIL-HYDROCHLOROTHIAZIDE 72 67 26 35
LOVASTATIN 70 60 27 17
TRIAMTERENE-HCTZ 67 62 28 42
DONEPEZIL HCL 67 67 28 33
ALLOPURINOL 67 65 28 28
TRAMADOL HCL 61 59 31 34
RANITIDINE HCL 60 46 32 52
PRAVASTATIN SODIUM 60 60 32 20
KLOR-CON M20 59 56 34 99
ZETIA 58 58 35 87
ADVAIR DISKUS 57 53 36 37
GLIMEPIRIDE 57 57 36 48
FLUTICASONE PROPIONATE 55 52 38 29
DIOVAN 55 55 38 58
SERTRALINE HCL 52 48 40 25
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 28, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.